All Articles

A new study identifies a hidden culprit in Long COVID patients' blood, offering a tangible target for Aethlon Medical's Hemopurifier device.

The Embassy of Nature is launching a radical plan to trade natural wealth on capital markets. Can this 'Environmental Capitalism' save our planet, or just commodify it?

After a tough year overshadowed by a past blockbuster, Cineverse is radically remaking itself into a tech-first powerhouse with two major acquisitions.

The strategic hire of Michael Kenworthy as CTO signals VulcanForms' intent to dominate advanced manufacturing amid a push for secure domestic supply chains.

Raytheon's massive AIM-9X missile contract is more than a number. It's a signal of a global shift toward stockpiling and a new era of strategic defense.

Hennick Humber Hospital's $750k grant isn't just funding; it's activating a digital and human network to rewrite Canada's response to the opioid crisis.

As AbbVie prepares its Q2 earnings call, a $10.9B acquisition and a revitalized oncology pipeline reveal a firm aggressively charting its post-Humira future.

In China's fast-paced stock market, a delay is a loss. See how Aurora Mobile's tech is giving one financial app the speed to build trust and win users.

The firm's explosive growth, fueled by hyper-focused AI funds, shows how niche ETFs are challenging industry giants and reshaping how we invest in technology.

Peterborough Regional Health Centre pioneers a new era of safety with AI-driven screening, aiming to protect without creating barriers. Is this the future?

The U.S. cyber insurance market faces a correction as falling premiums collide with rising claims, creating a paradox that threatens future stability.

A key EU panel backs Datroway for a deadly breast cancer, signaling a new standard of care and a massive victory for the pharma duo's ADC platform strategy.

Nevada King Gold Corp. moves to the OTCQX Best Market, enhancing visibility and credibility. What does this strategic move mean for the company and investors?

Tradr's new 2x leveraged ETFs target volatile tech stocks, offering sophisticated traders amplified gains. But with extreme risks, are they a step too far?

The appointment of Mark Eisner is more than a new name on the board. It's a strategic move to de-risk a high-stakes pipeline in a multi-billion dollar market.

A strategic alliance between DEEPX, Sixfab, and Raspberry Pi is democratizing Physical AI, moving intelligence from the cloud to the edge we can touch.

After an initial rejection, Acadia Pharma's DAYBU® wins a key EU recommendation, offering the first-ever targeted therapy for Rett syndrome in Europe.

Warburg Pincus's acquisition of Network Plus signals a major PE push into UK infrastructure, a high-stakes bet on growth amid a critical energy transition.

A federal court handed Bunker Hill Mining a decisive victory, dismissing key claims and allowing the firm to pursue costs from its rival, Crescent Mine.